Day: June 28, 2023

Tech experts outline the four ways AI could spiral into worldwide catastrophes

6:00 am June 28, 2023

Tech experts, Silicon Valley billionaires and everyday Americans have voiced their concerns that artificial intelligence could spiral out of control and lead to the downfall of humanity. Now, researchers at the Center for AI Safety have detailed exactly what “catastrophic” risks AI poses to the world. “The world as we know it is not normal,” […]

Read More

Gun-toting dad who thwarted mass shooting despite being shot in head now training others on self-defense

6:00 am June 28, 2023

One year ago on July 3, Arizona resident and concealed-carry holder Raul Mendez and his family were enjoying a Fourth of July party before shots rang out and left their lives changed forever. Mendez was shot in the head as suspect Jason Hunt opened fire on the partygoers, leaving two men dead and four others, […]

Read More

Israel embraces cutting-edge AI to thwart cyberattacks, foil terrorism

6:00 am June 28, 2023

Israel continues to explore innovative uses for artificial intelligence (AI) in various aspects of security and law enforcement, helping to foil numerous threats. “AI technology has been incorporated quite naturally into the Shin Bet’s interdiction machine,” Shin Bet Director Ronen Bar said in a speech to the Cyber Week conference in Israel. “Using AI, we […]

Read More

The trans-sport two-step dishonors female athlete pioneers like my mom

6:00 am June 28, 2023

The Senate Judiciary Committee recently held a hearing entitled, “Protecting Pride: Defending the Civil Rights of LGBTQ+ Americans,” where former University of Kentucky women’s swimmer Riley Gaines gave emotional testimony about her experience losing an NCAA championship to a male transgender swimmer, and having to change in a locker room with the 6’4″ 22-year-old biological […]

Read More

First AI-generated drug enters human clinical trials, targeting chronic lung disease patients

6:00 am June 28, 2023

The first-ever drug generated by artificial intelligence has entered Phase 2 clinical trials, with the first dose successfully administered to a human, Insilico Medicine announced yesterday. The drug, currently referred to as INS018_055, is being tested to treat idiopathic pulmonary fibrosis (IPF), a rare, progressive type of chronic lung disease.  The 12-week trial will include […]

Read More